What is Flashback Technologies?
Flashback Technologies specializes in transforming fragmented medical data into actionable intelligence using advanced machine learning. Their flagship product, the CipherOx CRI-M1, is an FDA-cleared blood loss monitor that trends acute blood loss through the Compensatory Reserve Index. The company serves healthcare organizations, researchers, and life-science teams, providing solutions for clinical monitoring, operational optimization, and regulatory support. By improving analytical clarity and decision-making, Flashback Technologies aims to empower innovation across clinical and research environments.
How much funding has Flashback Technologies raised?
Flashback Technologies has raised a total of $3.5M across 2 funding rounds:
Series A
$2.3M
Private Equity
$1.2M
Series A (2014): $2.3M with participation from Pacific Advantage Capital
Private Equity (2016): $1.2M, investors not publicly disclosed
Key Investors in Flashback Technologies
Pacific Advantage Capital
Pacific Advantage Capital is a private investment partnership investing globally across special situations, private equity, and growth equity. They are an opportunistic investor seeking compelling risk-adjusted returns across various markets and structures.
What's next for Flashback Technologies?
The substantial enterprise-level funding indicates Flashback Technologies is poised for significant scaling and market expansion. This capital injection will likely fuel further development of their AI-driven medical data intelligence platform and enhance the reach of their FDA-cleared CipherOx CRI-M1 monitor. Strategic investments of this magnitude typically signal a move towards broader commercialization, potential partnerships, and strengthening their competitive position in the health-tech landscape.
See full Flashback Technologies company page
